English  |  正體中文  |  简体中文  |  Items with full text/Total items : 43238/136796
Visitors : 2053914      Online Users : 170
RC Version 3.1 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://ntur.lib.ntu.edu.tw/handle/246246/166655

Title: Determination of Smni/Smn2 Gene Dosage by a Quantitative Genotyping Platform Combining Capillary Electrophoresis and Maldi-Tof Mass Spectrometry
Authors: 蘇怡寧;廖信凱;陳玉如
SU, YI-NING;LIAO, HSIN-KAI;CHEN, YU-JU
Contributors: 基因醫學部
Date: 2006
Issue Date: 2009-09-23T02:52:13Z
Abstract: Background: Spinal muscular atrophy (SMA) is a common inherited and fatal neuromuscular disease caused by deletions and/or mutations that lead to altered concentrations of proteins encoded by the survival motor neuron genes SMN1 and SMN2. Because of the high incidence ( at least 1 in 10 000 live births and a carrier frequency of 1 in 35 to 1 in 50) and severity of the disease, precise quantification of SMN1 and SMN2 gene copy numbers is essential for diagnosis and genetic counseling. Methods: We developed a genotyping platform combining capillary electrophoresis and matrix- assisted laser desorption/ ionization time-of-flight mass spectrometry ( MALDI-TOF MS) to quantify absolute gene dosage. The absolute gene dosage can be determined by a multiplexed competitive PCR protocol followed by capillary electrophoresis analysis. The relative SMN1/SMN2 ratio can be analyzed by PinPoint assay followed by MALDI-TOF MS analysis. Results: The complementary assays were evaluated in confirmed cases including 9 affected patients, 33 carriers, and 478 healthy individuals from the general population. We were able to determine all genotypes with different SMN1/SMN2 gene copy number ratios, which unambiguously diagnosed carrier status and the severity of SMA with 100% specificity. Conclusions: This quantitative genotyping platform is suitable for detection of SMA. The described approach may serve as a general quantitative genotyping method for molecular diagnosis of other inheritable diseases. (C) 2006 American Association for Clinical Chemistry.
Relation: CLINICAL CHEMISTRY v.52 n.3 pp.367-369
Appears in Collections:[附設醫院基因醫學部] Periodical Articles

Files in This Item:

There are no files associated with this item.



All items in NTUR are protected by copyright, with all rights reserved.

 

DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team  - Feedback